{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Response and durability of response will be based on hematologic Complete Response or Partial Response and date of relapse or death","groups":[{"description":"Mobilization with filgrastim Second autologous peripheral blood stem cell transplant with melphalan conditioning\n\nfilgrastim: 16mcg/kg IV daily beginning three days prior to stem cell collection through last day of SCC\n\nmelphalan: 140-200 mcg/kg IV over two days\n\nautologous bone marrow transplantation: infusion of previously collected stem cells on Day 0\n\nperipheral blood stem cell transplantation: infusion of previously collected stem cells on Day 0","id":"OG000","title":"2nd SCT"}],"populationDescription":"No data were collected or analyzed due to study termination","reportingStatus":"POSTED","timeFrame":"3 months after treatment and annually","title":"Response and Durability of Response","type":"PRIMARY"}